Bortezomib liquid Spirig HC 3.5 mg/1.4 ml
Bortezomib liquid Spirig HC 3.5 mg/1.4 ml is a medicine authorised by Swissmedic under authorisation number 67421. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 December 2019 and the authorisation is valid without a time limit. ATC code L01XG01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67421 |
|---|---|
| Name | Bortezomib liquid Spirig HC 3.5 mg/1.4 ml |
| Full name | Bortezomib liquid Spirig HC 3.5 mg/1.4 ml, Injektionslösung |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XG01 |
| First authorisation | 09 December 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bortezomib liquid Spirig HC 3.5 mg/1.4 ml, Injektionslösung | A | 09 December 2019 |
| 2 | Bortezomib liquid Spirig HC 7 mg/2.8 ml, Injektionslösung | A | 08 December 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01XG01 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01XG01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bortezomib liquid Spirig HC 3.5 mg/1.4 ml authorised in Switzerland?
Yes. Bortezomib liquid Spirig HC 3.5 mg/1.4 ml is authorised by Swissmedic under authorisation number 67421, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Bortezomib liquid Spirig HC 3.5 mg/1.4 ml have?
Bortezomib liquid Spirig HC 3.5 mg/1.4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Bortezomib liquid Spirig HC 3.5 mg/1.4 ml?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.